# Clinical Trial in Children Between 3 Months and 14 Years Old to Evaluate the Efficacy and Safety of Gelatin Tannate in the Treatment of Acute Diarrhea (INDIGO)

> **NCT04065529** · PHASE3 · COMPLETED · sponsor: **Ferrer Internacional S.A.** · enrollment: 150 (actual)

## Conditions studied

- Diarrhea

## Interventions

- **COMBINATION_PRODUCT:** Gelatin tannate (GT) + oral rehydration solution (ORS) + Zinc supplementation
- **COMBINATION_PRODUCT:** placebo + ORS + Zinc supplementation

## Key facts

- **NCT ID:** NCT04065529
- **Lead sponsor:** Ferrer Internacional S.A.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-09-11
- **Primary completion:** 2020-06-11
- **Final completion:** 2020-06-11
- **Target enrollment:** 150 (ACTUAL)
- **Last updated:** 2020-11-04

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04065529

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04065529, "Clinical Trial in Children Between 3 Months and 14 Years Old to Evaluate the Efficacy and Safety of Gelatin Tannate in the Treatment of Acute Diarrhea (INDIGO)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04065529. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*